Biopharmaceutical company Sosei Group received both Licensing Deal of the Year and Executive of the Year at the first Informa Pharma Intelligence Awards Japan. The Informa Pharma Intelligence Awards Japan…
…healthcare sector and is the author of over 30 peer-reviewed scientific articles. Dr Anvar holds a PhD in Medicine from Leiden University, and an MSc in Bioinformatics and Artificial Intelligence…
Technology company PeakData has raised €12.1 million in Series A funding to support its artificial intelligence (AI) platform. Launched in 2018, PeakData enables pharmaceutical companies to uncover the whole therapeutic…
…signs $20m research agreement with Atomwise Artificial intelligence (AI) company Atomwise has signed an exclusive research collaboration with Sanofi to use its AtomNet platform for computational discovery and research of…
…transformative therapeutics and diagnostics in chronic multi-factorial diseases,” said Angeli Möller, PhD, Vice-Chairperson and co-founder of the Alliance for Artificial Intelligence in Healthcare, the global advocacy organization for applying AI…
…big data and artificial intelligence (AI). Access the summer issue on the app The DDW App can be downloaded for free for Apple and Android devices to access content online…
…digital twin to assist CAR-T development Artificial intelligence (AI) solutions provider Phesi has developed a digital twin for Cytokine Release Syndrome (CRS) patients following CAR-T therapy. SMC opens new pharma…
…opportunity to accelerate our growth plans. We look forward to welcoming new, highly talented software specialists and scientists dedicated to delivering our best-in-class in silico technologies and Artificial Intelligence platforms.”…
Artificial intelligence (AI) solutions provider Phesi has developed a digital twin for Cytokine Release Syndrome (CRS) patients following CAR-T therapy. Phesi has developed the digital twin for CRS in order…
…other regions. Benchling launches beta for biomolecule design R&D cloud platform provider Benchling has launched a new artificial intelligence (AI) programme to help scientists predict 3D structures of novel proteins….
…diseases and artificial intelligence network science-based algorithms. The platform identifies biologically similar patients and drug targets that are specific to those patients to improve response rates. Official comments “By partnering…
R&D cloud platform provider Benchling has launched a new artificial intelligence (AI) programme to help scientists predict 3D structures of novel proteins. The company has launched a beta version of…
Drug discovery and development is a challenging multiparameter optimisation problem. Harnessing the power of artificial intelligence (AI) can help accurately predict the behaviour and properties of small molecules. In this…
Artificial intelligence company Iktos has announced a collaboration with drug discovery company Sygnature Discovery in a deal designed to accelerate drug discovery and development. The three-year deal will see Sygnature…
…and artificial intelligence to deliver behavioural change health benefits and is being applied to chronic illnesses such as diabetes and ulcerative colitis. Sidekick is working with companies including Pfizer and…
